Application Nr Approved Date Route Status External Links
NDA022517 None Sublingual None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Nocdurna Is Indicated For The Treatment Of Nocturia Due To Nocturnal Polyuria In Adults Who Awaken At Least 2 Times Per Night To Void. In The Nocdurna Clinical Trials Nocturnal Polyuria Was Defined As Night-Time Urine Production Exceeding One-Third Of The 24-Hour Urine Production. Before Starting Nocdurna: Evaluate The Patient For Possible Causes For The Nocturia, Including Excessive Fluid Intake Prior To Bedtime, And Address Other Treatable Causes Of Nocturia. Confirm The Diagnosis Of Nocturnal Polyuria With A 24-Hour Urine Collection, If One Has Not Been Obtained Previously. Nocdurna Is A Vasopressin Analog Indicated For The Treatment Of Nocturia Due To Nocturnal Polyuria In Adults Who Awaken At Least 2 Times Per Night To Void. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Desmopressin Acetate

Comments